原料药中间体
-
5-氯-2-[(5R)-六氢-5-甲基-1H-1,4-二氮杂卓-1-基]苯并恶唑
Merck’s Sleep Drug Suvorexant (Trade Name:Belsomra) was approved on August 13, 2014 by the U.S. Food and Drug Administration (FDA) to treat insomnia.
-
5-甲基-2-(2H-1,2,3-三唑-2-基)苯甲酸
Product Name 5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid CAS Number 956317-36-5 Appearance White solid Assay 99～102% Packing 5g;10g;25g;50g;100g;1kg Usage Suvorexant -
苏沃雷生
